Morgan Stanley
GNLX icon

Morgan Stanley’s Genelux GNLX Stock Holding History

Morgan Stanley’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Sell
88,048
-4,141
-4% -$11.3K ﹤0.01% 5843
2025
Q4 		$402K Buy
92,189
+31,545
+52% +$170K ﹤0.01% 5623
2025
Q3 		$255K Buy
60,644
+4,134
+7% +$14.7K ﹤0.01% 5797
2025
Q2 		$162K Sell
56,510
-12,500
-18% -$33K ﹤0.01% 5933
2025
Q1 		$186K Buy
69,010
+15,170
+28% +$56.9K ﹤0.01% 5758
2024
Q4 		$127K Buy
53,840
+23,916
+80% +$63.6K ﹤0.01% 5967
2024
Q3 		$70.9K Sell
29,924
-59,267
-66% -$130K ﹤0.01% 6119
2024
Q2 		$174K Buy
89,191
+29,853
+50% +$101K ﹤0.01% 5741
2024
Q1 		$382K Sell
59,338
-64,480
-52% -$586K ﹤0.01% 5432
2023
Q4 		$1.73M Buy
123,818
+93,915
+314% +$1.48M ﹤0.01% 4997
2023
Q3 		$732K Buy
29,903
+26,144
+696% +$663K ﹤0.01% 4976
2023
Q2 		$123K Buy
3,759
+1,775
+89% +$49.9K ﹤0.01% 5854
2023
Q1 		$55K Buy
+1,984
New +$32.2K ﹤0.01% 6250

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley's GNLX Position: Q1 2026 in Review

Morgan Stanley reduced its Genelux (GNLX) stake by 4.5% in Q1 2026, selling an estimated $11.3K and leaving 88,048 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #5843.

Morgan Stanley first reported a position in GNLX in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.73M in Q4 2023. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Morgan Stanley held 88,048 shares of Genelux worth $213K as of Q1 2026.
  • Morgan Stanley sold 4,141 Genelux shares in Q1 2026, an estimated $11.3K.
  • Genelux made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5843 holding.
  • Morgan Stanley first reported a position in Genelux in Q1 2023 and has held it in 13 quarters since.
  • Morgan Stanley's Genelux position peaked at $1.73M in Q4 2023.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.